IF a bivalent virus-like particle (VLP) vaccine co-displaying extracellular domain peptides of both GPNMB (10 μg) and uPAR/PLAUR (10 μg) conjugated to a Qβ or HBcAg VLP scaffold, adjuvanted with CpG-1826 (50 μg), administered subcutaneously at weeks 0, 3, and 6 is administered to 20-month-old, sex-balanced C57BL/6J mice,

THEN the bivalent vaccine will achieve ≥40% greater reduction in total senescent cell burden (quantified by p16^Ink4a^, p21^Cip1^, and SA-β-galactosidase co-staining) in both aortic root and liver tissue — compared to either GPNMB-only or uPAR-only monovalent vaccination — and will produce a disproportionate (non-additive, synergistic) reduction in circulating cell-free mitochondrial DNA (cf-mtDNA) and SASP cytokines (IL-6, IL-1β, MMP-3),

BECAUSE of the following step-by-step mechanistic chain:

1. uPAR+ senescent cells are the primary SASP effectors in aged tissues. Amor et al. demonstrated that uPAR (PLAUR) is broadly induced across diverse senescent cell populations and is particularly enriched on cells exhibiting proteolytic and secretory activity, forming the core of the SASP-amplifying compartment in liver and vascular tissues. (uPAR broadly marks SASP-active senescent cells across tissues)[https://doi.org/10.1038/s41586-020-2403-9]

2. SASP-driven paracrine senescence generates secondary GPNMB+ lysosomal-stressed senescent cells. IL-1α, IL-6, and reactive oxygen species secreted by uPAR+ SASP-active senescent cells propagate bystander senescence in adjacent endothelial cells and macrophages, which — under the lipid and lysosomal stress conditions of aged aortic root and steatotic liver — upregulate GPNMB as a consequence of lysosomal membrane permeabilization and TFEB-driven transcription. The GPNMB+ population therefore represents a downstream, SASP-induced senescent compartment, not merely a parallel one. [SPECULATIVE: direct causal link from uPAR+ SASP → GPNMB+ bystander senescence is inferred from SASP paracrine biology; direct single-cell co-trajectory data in aged C57BL/6J aorta is not yet published]

3. Monovalent uPAR-only vaccination clears SASP effectors but leaves GPNMB+ residual burden. Because GPNMB+ cells are downstream products of paracrine senescence that have already accumulated by 20 months, their clearance requires direct immune targeting; removal of their upstream drivers (uPAR+ cells) alone is insufficient to eliminate established GPNMB+ senescent burden within the vaccine window. This mirrors the finding that broad-spectrum senolytics, but not pathway-selective ones, are required for full tissue rejuvenation in aged animals. (Broad-spectrum galactose-prodrug senolytics eliminate multiple senescent cell types that single-mechanism agents miss)[https://doi.org/10.1111/acel.13133]

4. Monovalent GPNMB-only vaccination clears secondary lysosomal senescent cells but leaves SASP-active uPAR+ cells intact, perpetuating cf-mtDNA release and sterile inflammation. Accumulated senescent cells...

SENS category: LysoSENS

Key references: • doi.org/10.1038/s41586-020-2403-9] • doi.org/10.1111/acel.13133] • doi.org/10.1038/s41467-020-18039-x] • doi.org/10.1101/gad.302570.117] • doi.org/10.1038/s41467-020-18039-x].